Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
暂无分享，去创建一个
John D. Davis | L. Purcell | G. Yancopoulos | A. Baum | N. Stahl | C. Kyratsous | D. Burwen | K. Bar | D. Weinreich | D. Barouch | C. Hurt | N. Braunstein | N. Sarkar | E. Brown | M. Marovich | E. Forleo-Neto | L. Lipsich | J. Hamilton | G. Geba | Ruanne V. Barnabas | A. T. Dicioccio | P. Hou | R. Mohseni | K. Turner | I. Heirman | D. Ramesh | Yunji Kim | B. Musser | Kuo-Chen Chan | Meagan P. O'Brien | Flonza Isa | A. Mahmood | A. Hooper | B. Kowal | J. Krainson | R. Perez-Perez | M. Cohen | G. Herman | M. Cohen | Meagan P O'Brien